Journal of Hematology & Thromboembolic Diseases
Open Access

Urokinase Plasminogen Activator System and Hematologic Malignancies: Potential Role in Diagnosis and Therapy

Adel Gouri, Aoulia Dekaken, Aleksandra Klisic, Arifa Aissaoui, Mohamed Chefrour, Régis Guieu, Sadek Benharkat

DOI: 10.4172/2329-8790.1000S1e101

Increased Erythrocyte Count on Top of Bone Marrow Histology but not Serum EPO Level or JAK2 Mutation Load Discriminates between JAK2V617F Mutated Essential Thrombocythemia and Polycythemia Vera

Jan Jacques Michiels, Michael Medinger, Hendrik De Raeve, Wilfried Schroyens, Katrien Schelfout, Vincent Potters, Fransje Valster, Jenne Wielenga

Pulmonary Embolism Thrombolysis

Savas Ozsu

DOI: 10.4172/2329-8790.1000S1002

Validation of a Scoring System for Prediction of Clinical Outcome in the Offlabel Use of Recombinant Factor VIIa

Galila Zaher, Soheir Adam, Fatima Azher, Salwa Hindawi, Ghazi Damanhouri

DOI: 10.4172/2329-8790.1000S1003

Three Phenotypes of JAKV617F Mutated Essential Thrombocythemia and Early Thrombocythemic Stage of Polycythemia Vera in 10 Patients: Important to Differentiate because Natural History Differ

Jan Jacques Michiels, Zwi Berneman, Wilfried Schroyens, Kirsten van Lom, Konnie Hebeda, King H. Lam, Hendrik De Raeve

DOI: 10.4172/2329-8790.1000S1004